Signal-enhanced MRI contrast agents for neurodegeneration

This project aims to develop and validate new magnetic resonance technologies for early, non-invasive diagnosis of neurodegenerative diseases using metabolic contrast agents.

Subsidie
€ 150.000
2022

Projectdetails

Introduction

Despite decades of research, neurodegenerative diseases remain challenging to diagnose and identify on time. At the point external symptoms, such as memory or motor deficits, become evident, the patient has usually suffered irreparable neuronal damage. This not only decreases the quality of life and expectancy of the patient but also severely limits our ability to design new effective treatments and apply existing ones in a timely manner.

Early Diagnosis Approach

A promising approach for early diagnosis could be the visualization of metabolic changes in the brain. There are specific differences in the points of origin for different neurodegenerative diseases. The fact that the metabolism of neurons changes when they are exposed to internal or external stressors makes detecting changes in the metabolism of specific brain regions, in comparison to the rest of the organ, a potentially powerful tool for early diagnosis of neurodegeneration.

Development of Magnetic Resonance Technologies

During the course of my ERC starting grant, my team and I have developed new magnetic resonance technologies and contrast agents based on the body's own metabolites. These metabolic contrast agents can not only visualize the overall metabolism of observed tissues but also show differences in the rate of resulting metabolites, further increasing the potential diagnostic accuracy.

Before the developments made in my ERC project, especially a fast and simple approach to obtain such contrast agents was out of reach. In first experiments, we provided evidence that my approach can be used to detect the onset of Parkinson’s disease, one severe neurodegenerative illness.

Project Goals

With the project outlined in this PoC, we now aim to determine the feasibility of our technology as a clinical solution and a business opportunity. Our goals include:

  1. Enabling timely, straightforward, fast, and non-invasive diagnosis for neurodegenerative diseases.
  2. Bringing our technology into the clinics.
  3. Improving patient health on a global scale in the future.

The success of this project will be the first important step towards achieving these goals.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-10-2022
Einddatum31-3-2024
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EVpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC STG

Smart Cardiac Magnetic Resonance Delivering One-Click and Comprehensive Assessment of Cardiovascular Diseases

The project aims to revolutionize cardiovascular disease diagnosis and treatment by developing a fast, automated cardiac MRI system for comprehensive, one-click imaging and analysis.

€ 1.498.529